Division of Cardiology, Kingston General Hospital, Queen's University, Kingston, Ontario, Canada.
Cardiol J. 2010;17(2):184-8.
Acquired long QT interval has been widely reported to be a consequence of drug therapy and electrolyte disturbances. We describe two cases of multifactorial acquired QT interval prolongation and torsades de pointes. In the first case, the drugs venlafaxine, amiodarone and domperidone may have contributed to QT interval prolongation in a patient with hypokalemia and hypomagnesaemia. In the second case, QT interval prolongation occurred in a patient taking quetiapine and citalopram, and whose use of hydrocholorothiazide and history of chronic alcohol abuse likely contributed by rendering the patient hypokalemic. These cases highlight the potential risks associated with polypharmacy and demonstrate that though torsades de pointes is an uncommon arrhythmia, the combination of multiple factors known to prolong QT interval may precipitate this life-threatening arrhythmia.
获得性长 QT 间期已被广泛报道为药物治疗和电解质紊乱的后果。我们描述了两例多因素获得性 QT 间期延长和尖端扭转型室性心动过速。在第一个病例中,文拉法辛、胺碘酮和多潘立酮这三种药物可能导致低钾血症和低镁血症患者的 QT 间期延长。在第二个病例中,服用喹硫平和西酞普兰的患者出现 QT 间期延长,而氢氯噻嗪的使用和慢性酒精滥用史可能导致低钾血症,从而增加了 QT 间期延长的风险。这些病例强调了多药治疗相关的潜在风险,并表明尽管尖端扭转型室性心动过速是一种不常见的心律失常,但已知可延长 QT 间期的多种因素的组合可能会引发这种危及生命的心律失常。